全文获取类型
收费全文 | 3328574篇 |
免费 | 261147篇 |
国内免费 | 6943篇 |
专业分类
耳鼻咽喉 | 47162篇 |
儿科学 | 104585篇 |
妇产科学 | 91526篇 |
基础医学 | 466843篇 |
口腔科学 | 96206篇 |
临床医学 | 301465篇 |
内科学 | 651625篇 |
皮肤病学 | 71864篇 |
神经病学 | 279659篇 |
特种医学 | 128922篇 |
外国民族医学 | 1186篇 |
外科学 | 494850篇 |
综合类 | 78850篇 |
现状与发展 | 4篇 |
一般理论 | 1350篇 |
预防医学 | 275684篇 |
眼科学 | 78909篇 |
药学 | 244213篇 |
5篇 | |
中国医学 | 6952篇 |
肿瘤学 | 174804篇 |
出版年
2019年 | 26794篇 |
2018年 | 37944篇 |
2017年 | 28618篇 |
2016年 | 31549篇 |
2015年 | 35644篇 |
2014年 | 50600篇 |
2013年 | 76575篇 |
2012年 | 104759篇 |
2011年 | 110698篇 |
2010年 | 64626篇 |
2009年 | 61124篇 |
2008年 | 102928篇 |
2007年 | 109246篇 |
2006年 | 109893篇 |
2005年 | 106781篇 |
2004年 | 102154篇 |
2003年 | 98073篇 |
2002年 | 95765篇 |
2001年 | 152218篇 |
2000年 | 157064篇 |
1999年 | 132178篇 |
1998年 | 38736篇 |
1997年 | 35008篇 |
1996年 | 34646篇 |
1995年 | 33217篇 |
1994年 | 30874篇 |
1993年 | 28925篇 |
1992年 | 104341篇 |
1991年 | 100227篇 |
1990年 | 96642篇 |
1989年 | 92868篇 |
1988年 | 86122篇 |
1987年 | 84690篇 |
1986年 | 79979篇 |
1985年 | 76346篇 |
1984年 | 58302篇 |
1983年 | 49671篇 |
1982年 | 30405篇 |
1981年 | 27045篇 |
1979年 | 54111篇 |
1978年 | 38166篇 |
1977年 | 32077篇 |
1976年 | 30137篇 |
1975年 | 31470篇 |
1974年 | 38749篇 |
1973年 | 37118篇 |
1972年 | 34805篇 |
1971年 | 32048篇 |
1970年 | 30316篇 |
1969年 | 28279篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Marcel Toussaint Raymond J. Gilles Noura Azzabou Benjamin Marty Alexandre Vignaud Andreas Greiser Pierre G. Carlier 《Medicine》2015,94(43)
Delayed contrast enhancement after injection of a gadolinium-chelate (Gd-chelate) is a reference imaging method to detect myocardial tissue changes. Its localization within the thickness of the myocardial wall allows differentiating various pathological processes such as myocardial infarction (MI), inflammatory myocarditis, and cardiomyopathies. The aim of the study was first to characterize benign myocarditis using quantitative delayed-enhancement imaging and then to investigate whether the measure of the extracellular volume fraction (ECV) can be used to discriminate between MI and myocarditis.In 6 patients with acute benign myocarditis (32.2 ± 13.8 year-old, subepicardial late gadolinium enhancement [LGE]) and 18 patients with MI (52.3 ± 10.9 year-old, subendocardial/transmural LGE), myocardial T1 was determined using the Modified Look-Locker Imaging (MOLLI) sequence at 3 Tesla before and after Gd-chelate injection. T1 values were compared in LGE and normal regions of the myocardium. The myocardial T1 values were normalized to the T1 of blood, and the ECV was calculated from T1 values of myocardium and blood pre- and post-Gd injection.In both myocarditis and MI, the T1 was lower in LGE regions than in normal regions of the left ventricle. T1 of LGE areas was significantly higher in myocarditis than in MI (446.8 ± 45.8 vs 360.5 ± 66.9 ms, P = 0.003) and ECV was lower in myocarditis than in MI (34.5 ± 3.3 vs 53.8 ± 13.0 %, P = 0.004).Both inflammatory process and chronic fibrosis induce LGE (subepicardial in myocarditis and subendocardial in MI). The present study demonstrates that the determination of T1 and ECV is able to differentiate the 2 histological patterns.Further investigation will indicate whether the severity of ECV changes might help refine the predictive risk of LGE in myocarditis. 相似文献
43.
44.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
45.
46.
47.
48.
Rosario Gulias-Cañizo Anell Lagunes-Guillén Arturo González-Robles Erika Sánchez-Guzmán Federico Castro-Muñozledo 《Burns : journal of the International Society for Burn Injuries》2019,45(2):398-412
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献49.
50.